Nxera Pharmas QUVIVIQ (daridorexant) 25mg and 50mg Receives Approval in Taiwan for the Treatment of Insomnia
Nxera’s partner Holling Bio-Pharma Corp. will commercialize QUVIVIQ® in Taiwan, a market with…
Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma
April 10, 2026 17:02 ET | Source: Replimune, Inc. WOBURN, Mass., April…
Overcoming Onychomycosis Claims Evaluated: Blue Heron Health News Nail Fungus Treatment Program is On Sale
Boise, ID, April 03, 2026 (GLOBE NEWSWIRE) -- This release is based…
New SPRAVATO (esketamine nasal spray) data support robust effectiveness and show durable effect for treatment resistant depression in a real-world setting
Johnson & Johnson presents findings from the largest European real-world dataset for…
CityUHK researchers unveil the mystery of “Asian Flush” mechanism, pioneering new directions in precision treatment for heart attacks
HONG KONG, March 12, 2026 /PRNewswire/ -- Approximately 40% of the East…
Zealthy Hydroquinone 2026: Compounded Prescription Details, Online Dermatology Consultation Pricing, and What Consumers Should Verify Before Starting Treatment
New York, NY, Feb. 27, 2026 (GLOBE NEWSWIRE) -- This article contains…
Zealthy ED Platform in 2026 (Including Hardies Sublingual Formulations): Telehealth ED Treatment Options, Compounded Medication Pricing, and What Consumers Should Verify Before Starting
New York, NY, Feb. 27, 2026 (GLOBE NEWSWIRE) -- This article contains…
Discovery linking gut bacteria to cancer treatment wins the Bial Award in Biomedicine and earns 350,000 prize
A study published in Science reveals that a healthy gut microbiota can…
U.S. Food and Drug Administration (FDA) Accepts Tevas New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-‘749) for the Once-Monthly Treatment of Schizophrenia in Adults
Olanzapine long-acting injectable (LAI) suspension (TEV-'749) has the potential to offer the…
MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program
Month over Month Growth of 336% and 54% Reduction in Customer Acquisition…
